# Koios Medical, Inc. — Form D

Koios Medical, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-28. The offering totals $500.0M, of which $130.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-05-28
- Form: D
- Accession: 0001764417-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500.0M
- Amount sold: $130.0M
- Remaining: $370.0M
- Minimum investment: $20K
- Investors: 4
- Date of first sale: 2024-05-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-514383

## Issuer

- Name: Koios Medical, Inc.
- CIK: 0001764417
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 242 W. 38TH STREET, NEW YORK, NY, 10018
- Phone: 732-529-5755

## Officers, directors & promoters (19)

| Name | Role | Location |
| --- | --- | --- |
| CHRISTINE CHAD LI | Director | SINGAPORE, U0 |
| GREGORY CHAD MORAN | Director | COLUMBUS, OH |
| ROBERT CHAD MCCLENNAN | Director | NEW YORK, NY |
| ROBERT CHAD MCCLENNAN | Executive Officer | NEW YORK, NY |
| ROBERT CHAD MCCLENNAN | Promoter | NEW YORK, NY |
| GRAHAM ANDERSON | Executive Officer | NEW YORK, NY |
| GRAHAM ANDERSON | Promoter | NEW YORK, NY |
| MARK CHAD GLASGOLD | Director | PRINCETON, NJ |
| John Li Walker | Executive Officer | New York, NY |
| John Li Walker | Promoter | New York, NY |
| Robert Li McClennan | Executive Officer | New York, NY |
| Robert Li McClennan | Promoter | New York, NY |
| Gregory Li Moran | Director | Columbus, OH |
| Christine Li Shuling | Executive Officer | Chiyoda-ku, Tokyo, M0 |
| Christine Li Shuling | Promoter | Chiyoda-ku, Tokyo, M0 |
| Mark Li Glasgold | Director | Princeton, NJ |
| Gregory E Moran | Director | Columbus, OH |
| Mark E Glasgold | Director | Princeton, NJ |
| William E Peterson | Director | Fairfax, VA |

## Other filings by this issuer (6)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-12-23](https://search.stillhousedata.com/formd/0001764417-25-000003) | D | — | — |
| [2024-06-24](https://search.stillhousedata.com/formd/0001764417-24-000003) | D/A | $500K | $170K |
| [2023-02-17](https://search.stillhousedata.com/formd/0001764417-23-000001) | D | $12.0M | $8.0M |
| [2022-08-08](https://search.stillhousedata.com/formd/0001764417-22-000002) | D | $5.0M | $2.6M |
| [2021-02-03](https://search.stillhousedata.com/formd/0001764417-21-000002) | D | $3.0M | $280K |
| [2019-01-11](https://search.stillhousedata.com/formd/0001764417-19-000001) | D | $11.0M | $5.0M |

## More

- [CIK 1764417 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1764417&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001764417-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.